Skip to content

Food and Drug Regulations

C.R.C., c. 870

In forceCurrent to September 30, 2026 HistoryMade under: Food and Drugs Act

Follow

Part C — Drugs › Division 8

Sale of New Drug for Emergency Treatment

Section C.08.011.2

  •  (1) Despite subsection C.01A.004(1), the holder of an establishment licence may import a new drug in accordance with a letter issued under subsection C.08.011.1(1).

  • (2) Section C.01A.006 and Divisions 2 to 4, except for the following provisions, do not apply to the importation of a new drug referred to in the letter of authorization:

    • (a) sections C.02.003.1 and C.02.004, as they apply to the storage of the new drug by the holder of an establishment licence;

    • (b) section C.02.006, as it applies to the storage of the new drug by the holder of an establishment licence;

    • (c) subsection C.02.012(1);

    • (c.1) section C.02.012.1, as it applies to the storage of the new drug by the holder of an establishment licence;

    • (d) sections C.02.013 and C.02.014;

    • (e) section C.02.015, as it applies to the storage and transportation of the new drug by the holder of an establishment licence;

    • (f) subsection C.02.021(1), as it applies to the storage of the new drug by the holder of an establishment licence;

    • (g) subsection C.02.022(1);

    • (h) section C.02.023;

    • (i) subsection C.02.024(1); and

    • (j) section C.03.013.

    • (k) [Repealed, SOR/2024-238, s. 38]

  • SOR/2020-212, s. 2
  • SOR/2024-238, s. 38
.

Amended by SOR/2024-238, s. 38, in force on December 18, 2024

Unofficial reproduction of the consolidated text published by the Department of Justice Canada, permitted by the Reproduction of Federal Law Order. Only the official text is authoritative.